Intervention

Open-label, PK Cohort (Cohort B): ponsegromab medium dose

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

A Study of Ponsegromab in People With Heart FailureNCT05492500 · 2022-09-26

TERMINATED

Common conditions

Heart Failure1

Leading sponsors

Pfizer1

Trial status mix

TERMINATED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.